Pure Cycle Corporation Announces Receipt Of Notice To Nominate Director Candidates

Pure Cycle Corporation announced it received a formal notice to nominate a director candidate, signaling potential governance changes.

Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) Announces Letter Of Intent For Proposed Reverse Takeover Transaction With Privately Held Operating Company

Autozi Internet Technology (Nasdaq: AZI) reveals a letter of intent for a proposed reverse takeover with a private company, signaling strategic growth plans.

IMC Rare Earths Ltd Announces Closing Of Full Exercise Of Underwriters’ Option To Purchase Additional Shares

IMC Rare Earths Ltd has fully exercised its underwriters’ option to purchase additional shares, strengthening its capital position. Details confirmed from GlobeNewswire.

Shareholder Alert: Ademi LLP Investigates Claims Of Securities Fraud Against Honeywell Aerospace Inc.

Ademi LLP announces investigation into potential securities fraud involving Honeywell Aerospace, prompting shareholder concern and regulatory scrutiny.

Outlook Therapeutics To Report Third Quarter Fiscal Year 2026 Financial Results And Host A Corporate Update Conference Call And Webcast On August 14, 2026

Outlook Therapeutics is scheduled to report its third quarter fiscal year 2026 financial results on August 14, 2026, and will hold a conference call and webcast.

Nasdaq Surges In Global Coverage

Nasdaq’s recent surge in global media mentions signals increased investor interest and market activity, with coverage rising over twofold according to GDELT data.

Michelle W Bowman: Responsible Innovation And Financial Inclusion

Federal Reserve’s Michelle Bowman emphasizes responsible innovation to promote financial inclusion, highlighting ongoing efforts and future challenges.

Lithium Ionic Announces Withdrawal Of Shareholder Requisition For A Special Meeting

Lithium Ionic has announced it is withdrawing its request for a special shareholder meeting, ending a recent attempt to gather support for specific proposals.

InnoCare Announces Orelabrutinib In Combination With Mesutoclax Granted Breakthrough Therapy Designation In China

InnoCare’s combination therapy of Orelabrutinib and Mesutoclax has been granted Breakthrough Therapy designation in China, accelerating development for blood cancer treatment.

Farmers Merchants Bancorp Surges In Global Coverage

Farmers Merchants Bancorp experiences a significant surge in international coverage, with 25 mentions within a recent reporting window, highlighting increased global interest.